Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles.

[1]  W. Armstead,et al.  Selective Blockade of AT1 Receptor Attenuates Impairment of Hypotensive Autoregulation and Improves Cerebral Blood Flow after Brain Injury in the Newborn Pig , 2003, Anesthesiology.

[2]  W. Armstead,et al.  Prostaglandins contribute to impaired angiotensin II-induced cerebral vasodilation after brain injury. , 2002, Journal of neurotrauma.

[3]  P. Corvol,et al.  Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants. , 1998, European journal of pharmacology.

[4]  T. Hedner,et al.  Comparative Cardiovascular Effects of the Angiotensin II Type 1 Receptor Antagonists ZD 7155 and Losartan in the Rat , 1996, The Journal of pharmacy and pharmacology.

[5]  W. Armstead.  cGMP and cAMP in prostaglandin-induced pial artery dilation and increased CSF opioid concentration. , 1996, The American journal of physiology.

[6]  R. Carey,et al.  The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. , 1996, The Journal of clinical investigation.

[7]  C. Boulanger,et al.  Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. , 1995, Hypertension.

[8]  J. Bénessiano,et al.  Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[9]  W. Meng,et al.  Comparative Effects of Angiotensin‐(1‐7) and Angiotensin II on Piglet Pial Arterioles , 1993, Stroke.

[10]  M. Phillips,et al.  The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin , 1992, Brain Research.

[11]  S. Whitebread,et al.  Radioiodinated CGP 42112A: a novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptors. , 1991, Biochemical and biophysical research communications.

[12]  C. J. Blankley,et al.  Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. , 1991, Journal of medicinal chemistry.

[13]  M. Schambelan,et al.  Expression of AT2 receptors in the developing rat fetus. , 1991, The Journal of clinical investigation.

[14]  K. Einhäupl,et al.  Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles. , 1991, Circulation research.

[15]  A. Villringer,et al.  Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. , 1990, The American journal of physiology.

[16]  S. Whitebread,et al.  Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[17]  J. P. Gilmore,et al.  In Vivo Microscopy of the Cerebral Microcirculation Using Neonatal Allografts in Hamsters , 1988, Circulation research.

[18]  D. Heistad,et al.  Responses of cerebral arteries after ischemia and reperfusion in cats. , 1988, The American journal of physiology.

[19]  J. Seylaz,et al.  Generalized cerebral vasoconstriction induced by intracarotid infusion of angiotensin II in the rabbit , 1983, Brain Research.

[20]  J. Patterson,et al.  Vasoconstrictor Effect of Angiotensin on Pial Arteries 487 , 1978, Stroke.

[21]  R. Heath,et al.  Angiotensin-forming enzyme in human brain , 1975, Neuropharmacology.

[22]  D. Heistad,et al.  Regulation of the cerebral circulation: role of endothelium and potassium channels. , 1998, Physiological reviews.

[23]  T. Unger,et al.  AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. , 1998, Hypertension.

[24]  Phillips Mi.  Functions of Angiotensin in the Central Nervous System , 1987 .